Kenneth C. Cundy, PhD
Location: Santa Clara, California, United States
Kenneth C. Cundy has been our XenoPort Fellow since June 2012.† He was previously the senior vice president of preclinical and clinical sciences from June 2012 to November 2010. From 2004 to November 2010, Dr. Cundy was our senior vice president of pre-clinical development, and prior to that, he was our vice president of biopharmaceutics from 2000 to 2004. From 1992 to 2000, he was senior director of biopharmaceutics at Gilead Sciences, Inc. Prior to Gilead Sciences, from 1988 to 1992, Dr. Cundy was principal research investigator at Sterling Drug, a pharmaceutical division of Eastman Kodak Company. He received a BS from the University of Manchester and a PhD in pharmaceutical sciences from the University of Kentucky.